JP7579439B2 - Method and apparatus for analyzing membrane blocking substances, and method and apparatus for controlling chemical injection into separation membrane - Google Patents

Method and apparatus for analyzing membrane blocking substances, and method and apparatus for controlling chemical injection into separation membrane Download PDF

Info

Publication number
JP7579439B2
JP7579439B2 JP2023518644A JP2023518644A JP7579439B2 JP 7579439 B2 JP7579439 B2 JP 7579439B2 JP 2023518644 A JP2023518644 A JP 2023518644A JP 2023518644 A JP2023518644 A JP 2023518644A JP 7579439 B2 JP7579439 B2 JP 7579439B2
Authority
JP
Japan
Prior art keywords
membrane
reflection intensity
visible light
substance
unused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023518644A
Other languages
Japanese (ja)
Other versions
JPWO2022234751A1 (en
Inventor
卓 木田
勇規 中村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organo Corp
Original Assignee
Organo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organo Corp filed Critical Organo Corp
Publication of JPWO2022234751A1 publication Critical patent/JPWO2022234751A1/ja
Application granted granted Critical
Publication of JP7579439B2 publication Critical patent/JP7579439B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D65/00Accessories or auxiliary operations, in general, for separation processes or apparatus using semi-permeable membranes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D65/00Accessories or auxiliary operations, in general, for separation processes or apparatus using semi-permeable membranes
    • B01D65/02Membrane cleaning or sterilisation ; Membrane regeneration
    • B01D65/06Membrane cleaning or sterilisation ; Membrane regeneration with special washing compositions
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/27Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A20/00Water conservation; Efficient water supply; Efficient water use
    • Y02A20/124Water desalination
    • Y02A20/131Reverse-osmosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Mathematical Physics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Description

本発明は、分離膜を閉塞させる膜閉塞物質の分析方法及び分析装置、並びに分離膜の薬注制御方法及び薬注制御装置に関する。 The present invention relates to a method and apparatus for analyzing membrane blocking substances that block separation membranes, as well as a method and apparatus for controlling chemical injection into separation membranes.

分離膜を用いて被処理水を処理する水処理システムでは、被処理水に含まれる膜閉塞物質によって分離膜が徐々に閉塞することが知られている。分離膜の閉塞が進行すると水処理の効率が低下するため、一般的には酸やアルカリ等の洗浄薬液を用いて膜閉塞物質を溶解除去し、分離膜を初期状態へと回復させる。洗浄薬液を用いた分離膜の洗浄条件(洗浄薬液の種類、濃度、洗浄流速、水温等)は、膜閉塞の進行度や膜閉塞物質の種類等に応じて決定される。 In water treatment systems that use separation membranes to treat water to be treated, it is known that the separation membrane gradually becomes clogged due to membrane-blocking substances contained in the water to be treated. As the clogging of the separation membrane progresses, the efficiency of water treatment decreases, so generally, a cleaning solution such as an acid or alkali is used to dissolve and remove the membrane-blocking substances and restore the separation membrane to its initial state. The cleaning conditions for the separation membrane using a cleaning solution (type, concentration, cleaning flow rate, water temperature, etc. of the cleaning solution) are determined according to the degree of membrane clogging and the type of membrane-blocking substances, etc.

膜閉塞の進行度や膜閉塞物質の種類等は、例えば、水処理システムの運転を停止して閉塞した分離膜を取り外す、あるいは未使用の分離膜に交換し、閉塞した分離膜を分析することで判定する方法が考えられる。しかしながら、そのような方法は、分離膜の取り外し、洗浄後の再組み込み、あるいは分離膜の交換等の手間が発生すると共に、分析結果が得られるまでに時間を要するという課題がある。そこで、膜閉塞の進行度を推定するための技術や膜閉塞物質の種類を特定するための技術が検討されている。 One possible method for determining the degree of membrane blockage and the type of membrane-blocking substance is to stop operation of the water treatment system, remove the blocked separation membrane or replace it with an unused separation membrane, and then analyze the blocked separation membrane. However, such methods have issues in that they require the time and effort of removing the separation membrane, reinstalling it after cleaning, or replacing it, and they also require a long time to obtain analysis results. Therefore, technologies for estimating the degree of membrane blockage and technologies for identifying the type of membrane-blocking substance are being developed.

例えば、特許文献1には、分離膜で分離された濃縮水の一部を監視用分離膜へ送水し、監視用分離膜における濃縮水の透過量の絶対値またはその変化率、監視用分離膜の透過前後における濃縮水の差圧の絶対値またはその変化率等に基づいて、分離膜の膜閉塞の進行度を推定する技術が記載されている。For example, Patent Document 1 describes a technology in which a portion of the concentrated water separated by a separation membrane is sent to a monitoring separation membrane, and the degree of membrane blockage of the separation membrane is estimated based on the absolute value or rate of change of the amount of concentrated water permeated through the monitoring separation membrane, the absolute value or rate of change of the pressure difference of the concentrated water before and after permeation through the monitoring separation membrane, etc.

また、特許文献2には、分離膜を備える膜分離装置を透明な樹脂等で構成し、該分離膜の膜面をカラーセンサで経時的に観測することで、該膜面に付着する膜閉塞物質の種類を特定することが記載されている。Furthermore, Patent Document 2 describes a membrane separation device equipped with a separation membrane that is made of a transparent resin or the like, and the type of membrane-blocking substance adhering to the membrane surface is identified by observing the membrane surface over time with a color sensor.

上述した特許文献1は、膜閉塞の進行度を推定するための技術を提案したものであり、分離膜の膜面に付着した膜閉塞物質の種類を特定するものではない。したがって、特許文献1に記載された技術は、膜閉塞物質の種類に応じて適切な薬液を選択することができないという課題がある。The above-mentioned Patent Document 1 proposes a technology for estimating the degree of membrane blockage, but does not identify the type of membrane-blocking substance attached to the membrane surface of the separation membrane. Therefore, the technology described in Patent Document 1 has the problem that it is not possible to select an appropriate chemical solution depending on the type of membrane-blocking substance.

一方、特許文献2に記載された水処理システムでは、カラーセンサで観測された膜面の色から膜閉塞物質を特定するため、判別可能な膜閉塞物質の種類が限定されてしまうという課題がある。On the other hand, the water treatment system described in Patent Document 2 identifies membrane-blocking substances from the color of the membrane surface observed by a color sensor, which has the problem that the types of membrane-blocking substances that can be identified are limited.

特開2012-130823号公報JP 2012-130823 A 特開2019-166463号公報JP 2019-166463 A

本発明は上述したような背景技術が有する課題を解決するためになされたものであり、より多くの膜閉塞物質の種類の特定が可能な膜閉塞物質の分析方法及び分析装置、並びに該分析方法及び分析装置を用いる分離膜の薬注制御方法及び薬注制御装置を提供することを目的とする。The present invention has been made to solve the problems associated with the background art as described above, and aims to provide an analytical method and apparatus for membrane blocking substances that are capable of identifying a greater number of types of membrane blocking substances, as well as a method and apparatus for controlling chemical injection into a separation membrane that uses the analytical method and analytical apparatus.

上記目的を達成するため本発明の膜閉塞物質の分析方法は、試験水が通水された監視用分離膜に可視光を照射し、
前記監視用分離膜で反射した前記可視光の反射強度を可視光分光光度計で測定し、
測定した前記可視光の前記反射強度に基づいて膜の閉塞物質を特定し、
前記膜の閉塞物質を特定する工程は、
未使用の前記監視用分離膜である未使用膜及び想定される前記膜の閉塞物質である想定物質の前記反射強度を測定し、
前記未使用膜及び前記想定物質における前記可視光の波長光の差に対する前記反射強度の差である第1の傾きをそれぞれ算出し、
前記未使用膜及び前記想定物質の前記第1の傾きと、400~450nmまたは700~800nmの波長光における前記未使用膜の前記反射強度とを保存し、
前記試験水が通水された前記監視用分離膜である被監視膜の前記可視光の前記反射強度を測定し、
前記400~450nmまたは700~800nmの波長光における、前記被監視膜の前記反射強度が前記未使用膜の前記反射強度よりも小さいとき、前記被監視膜が閉塞していると判定し、
前記被監視膜における、前記可視光の波長光の差に対する前記反射強度の差である第2の傾きを算出し、
前記第1の傾きと前記第2の傾きとを比較することで、前記被監視膜を閉塞させている前記膜の閉塞物質を特定する方法である。
In order to achieve the above object, the present invention provides a method for analyzing membrane blocking substances, comprising: irradiating a monitoring separation membrane through which test water has been passed with visible light;
measuring the reflection intensity of the visible light reflected by the monitoring separation membrane with a visible light spectrophotometer;
identifying an obstructing substance in the membrane based on the measured reflected intensity of the visible light;
The step of identifying a membrane obstructing substance comprises:
Measure the reflection intensity of an unused membrane, which is the unused monitoring separation membrane, and an assumed substance, which is an assumed clogging substance of the membrane;
Calculating a first slope, which is a difference in reflection intensity with respect to a difference in wavelength of visible light in the unused film and the assumed substance, respectively;
storing the first gradient of the unused film and the assumed substance, and the reflection intensity of the unused film at a wavelength of 400 to 450 nm or 700 to 800 nm;
measuring the reflection intensity of the visible light from the monitored membrane, which is the monitoring separation membrane through which the test water is passed;
determining that the monitored film is clogged when the reflection intensity of the monitored film is smaller than the reflection intensity of the unused film for the light of the wavelength of 400 to 450 nm or 700 to 800 nm;
calculating a second gradient, which is a difference in reflection intensity with respect to a difference in wavelength of the visible light in the monitored film;
The method identifies a membrane occluding substance that is occluding the monitored membrane by comparing the first gradient with the second gradient.

本発明の膜閉塞物質の分析装置は、試験水が通水される監視用分離膜と、
前記監視用分離膜に可視光を照射し、前記監視用分離膜で反射した前記可視光の反射強度を測定する可視光分光光度計と、
測定した前記可視光の前記反射強度に基づいて膜の閉塞物質を特定する演算装置と、
を有し、
前記演算装置は、
前記可視光分光光度計で測定された未使用の前記監視用分離膜である未使用膜及び想定される前記膜の閉塞物質である想定物質の前記反射強度から、前記未使用膜及び前記想定物質における、前記可視光の波長光の差に対する前記反射強度の差である第1の傾きをそれぞれ算出し、前記未使用膜及び前記想定物質の前記第1の傾きと、400~450nmまたは700~800nmの波長光における前記未使用膜の前記反射強度とを保存し、
前記可視光分光光度計で測定された前記試験水が通水された前記監視用分離膜である被監視膜の前記可視光の前記反射強度に基づき、前記400~450nmまたは700~800nmの波長光における、前記被監視膜の前記反射強度が前記未使用膜の前記反射強度よりも小さいときに前記被監視膜が閉塞していると判定し、前記被監視膜における前記可視光の波長光の差に対する前記反射強度の差である第2の傾きを算出し、前記第1の傾きと前記第2の傾きとを比較することで、前記被監視膜を閉塞させている前記膜の閉塞物質を特定する。
The apparatus for analyzing membrane-blocking substances of the present invention comprises a monitoring separation membrane through which test water is passed,
a visible light spectrophotometer that irradiates the monitoring separation membrane with visible light and measures the reflection intensity of the visible light reflected by the monitoring separation membrane;
a computing device for identifying an obstructing substance in the membrane based on the measured reflection intensity of the visible light;
having
The computing device includes:
A first slope, which is a difference in reflection intensity with respect to a difference in wavelength light of the visible light in the unused membrane and the assumed substance, is calculated from the reflection intensity of the unused membrane, which is the unused monitoring separation membrane, measured by the visible light spectrophotometer, and the assumed substance, which is an assumed clogging substance of the membrane, and the first slope of the unused membrane and the assumed substance, and the reflection intensity of the unused membrane in the wavelength light of 400 to 450 nm or 700 to 800 nm are stored;
Based on the reflection intensity of the visible light of the monitored membrane, which is the monitoring separation membrane through which the test water has been passed, measured by the visible light spectrophotometer, it is determined that the monitored membrane is clogged when the reflection intensity of the monitored membrane at wavelengths of 400 to 450 nm or 700 to 800 nm is smaller than the reflection intensity of the unused membrane, and a second slope, which is the difference in reflection intensity versus the difference in wavelengths of the visible light in the monitored membrane, is calculated, and the first slope and the second slope are compared to identify the blocking substance in the membrane that is blocking the monitored membrane.

本発明の分離膜の薬注制御方法は、被処理水を分離膜により透過水と濃縮水とに分離し、
前記濃縮水の一部を試験水として監視用分離膜に通水し、
前記試験水が通水された前記監視用分離膜に可視光を照射し、
前記監視用分離膜で反射した前記可視光の反射強度を可視光分光光度計で測定し、
測定した前記可視光の前記反射強度に基づいて前記分離膜を閉塞させる膜閉塞物質を特定し、
前記膜閉塞物質を特定する工程は、
未使用の前記監視用分離膜である未使用膜及び想定される前記膜閉塞物質である想定物質の前記反射強度を測定し、
前記未使用膜及び前記想定物質における前記可視光の波長光の差に対する前記反射強度の差である第1の傾きをそれぞれ算出し、
前記未使用膜及び前記想定物質の前記第1の傾きと、400~450nmまたは700~800nmの波長光における前記未使用膜の前記反射強度とを保存し、
前記試験水が通水された前記監視用分離膜である被監視膜の前記可視光の前記反射強度を測定し、
前記400~450nmまたは700~800nmの波長光における、前記被監視膜の前記反射強度が前記未使用膜の前記反射強度よりも小さいとき、前記被監視膜が閉塞していると判定し、
前記被監視膜における、前記可視光の波長光の差に対する前記反射強度の差である第2の傾きを算出し、
前記第1の傾きと前記第2の傾きとを比較することで、前記被監視膜を閉塞させている前記膜閉塞物質を特定し、
特定された前記膜閉塞物質を溶解除去する薬液、または特定された前記膜閉塞物質による膜閉塞を抑制する薬液を、前記分離膜の通水ラインに薬注する方法である。
The chemical injection control method for a separation membrane of the present invention separates water to be treated into permeate and concentrated water by a separation membrane;
A part of the concentrated water is passed through a monitoring separation membrane as test water,
Irradiating the monitoring separation membrane through which the test water has passed with visible light;
measuring the reflection intensity of the visible light reflected by the monitoring separation membrane with a visible light spectrophotometer;
identifying a membrane blocking substance that blocks the separation membrane based on the measured reflection intensity of the visible light;
The step of identifying the membrane-occluding substance comprises:
Measure the reflection intensity of an unused membrane, which is the unused monitoring separation membrane, and an assumed substance, which is the assumed membrane blocking substance;
Calculating a first slope, which is a difference in reflection intensity with respect to a difference in wavelength of visible light in the unused film and the assumed substance, respectively;
storing the first gradient of the unused film and the assumed substance, and the reflection intensity of the unused film at a wavelength of 400 to 450 nm or 700 to 800 nm;
measuring the reflection intensity of the visible light from the monitored membrane, which is the monitoring separation membrane through which the test water is passed;
determining that the monitored film is clogged when the reflection intensity of the monitored film is smaller than the reflection intensity of the unused film for the light of the wavelength of 400 to 450 nm or 700 to 800 nm;
calculating a second gradient, which is a difference in reflection intensity with respect to a difference in wavelength of the visible light in the monitored film;
identifying the membrane blocking substance blocking the monitored membrane by comparing the first gradient with the second gradient;
The method comprises injecting a chemical solution for dissolving and removing the identified membrane-clogging substance, or a chemical solution for suppressing membrane clogging due to the identified membrane-clogging substance, into a water flow line of the separation membrane.

本発明の分離膜の薬注制御装置は、被処理水を透過水と濃縮水とに分離する分離膜を備えた膜分離装置と、
前記濃縮水の一部が試験水として通水される監視用分離膜と、
前記試験水が通水された前記監視用分離膜に可視光を照射し、前記監視用分離膜で反射した前記可視光の反射強度を測定する可視光分光光度計と、
測定した前記可視光の前記反射強度に基づいて前記分離膜を閉塞させる膜閉塞物質を特定する演算装置と、
特定された前記膜閉塞物質を溶解除去する薬液、または特定された前記膜閉塞物質による膜閉塞を抑制する薬液を、前記分離膜の通水ラインに薬注する制御装置と、
を有し、
前記演算装置は、
前記可視光分光光度計で測定された未使用の前記監視用分離膜である未使用膜及び想定される前記膜閉塞物質である想定物質の前記反射強度から、前記未使用膜及び前記想定物質における、前記可視光の波長光の差に対する前記反射強度の差である第1の傾きをそれぞれ算出し、前記未使用膜及び前記想定物質の前記第1の傾きと、400~450nmまたは700~800nmの波長光における前記未使用膜の前記反射強度とを保存し、
前記可視光分光光度計で測定された前記試験水が通水された前記監視用分離膜である被監視膜の前記可視光の前記反射強度に基づき、前記400~450nmまたは700~800nmの波長光における、前記被監視膜の前記反射強度が前記未使用膜の前記反射強度よりも小さいときに前記被監視膜が閉塞していると判定し、前記被監視膜における前記可視光の波長光の差に対する前記反射強度の差である第2の傾きを算出し、前記第1の傾きと前記第2の傾きとを比較することで、前記被監視膜を閉塞させている前記膜閉塞物質を特定する。
The chemical injection control device for a separation membrane of the present invention comprises: a membrane separation device having a separation membrane that separates water to be treated into permeate and concentrated water;
A monitoring separation membrane through which a portion of the concentrated water is passed as test water;
a visible light spectrophotometer for irradiating visible light onto the monitoring separation membrane through which the test water has passed and measuring the reflection intensity of the visible light reflected by the monitoring separation membrane;
a calculation device that identifies a membrane clogging substance that causes the separation membrane to be clogged based on the measured reflection intensity of the visible light;
A control device that injects a chemical solution for dissolving and removing the identified membrane blocking substance or a chemical solution for suppressing membrane blocking due to the identified membrane blocking substance into a water flow line of the separation membrane;
having
The computing device includes:
A first slope, which is a difference in reflection intensity with respect to a difference in wavelength light of the visible light in the unused membrane and the assumed substance, is calculated from the reflection intensity of the unused membrane, which is the unused monitoring separation membrane, and the assumed substance, which is the assumed membrane blocking substance, measured by the visible light spectrophotometer, and the first slope of the unused membrane and the assumed substance and the reflection intensity of the unused membrane in the wavelength light of 400 to 450 nm or 700 to 800 nm are stored;
Based on the reflection intensity of the visible light of the monitored membrane, which is the monitoring separation membrane through which the test water has been passed, measured by the visible light spectrophotometer, it is determined that the monitored membrane is clogged when the reflection intensity of the monitored membrane at wavelengths of 400 to 450 nm or 700 to 800 nm is smaller than the reflection intensity of the unused membrane, and a second slope, which is the difference in reflection intensity relative to the difference in wavelengths of the visible light in the monitored membrane, is calculated, and the first slope and the second slope are compared to identify the membrane blocking substance that is blocking the monitored membrane.

本発明の分離膜の薬注制御装置の一構成例を示すブロック図である。1 is a block diagram showing one configuration example of a chemical injection control device for a separation membrane according to the present invention; 図1に示した分析装置の一構成例を示す側断面図である。FIG. 2 is a side cross-sectional view showing one configuration example of the analysis device shown in FIG. 1 . 本発明の分離膜の薬注制御装置の変形例を示すブロック図である。FIG. 13 is a block diagram showing a modified example of the chemical injection control device for the separation membrane of the present invention. 膜閉塞物質のスペクトルの変化の一例を示すグラフである。1 is a graph showing an example of a change in the spectrum of a membrane occluding substance. 膜閉塞物質のスペクトルの変化の一例を示すグラフである。1 is a graph showing an example of a change in the spectrum of a membrane occluding substance. 図4及び5で示した想定物質のスペクトルデータの一例を示す表である。6 is a table showing an example of spectral data of the assumed substances shown in FIGS. 4 and 5. 図4及び5で示したスペクトルデータから求めた、実施例の膜閉塞物質の分析方法で用いるパラメータを示す表である。6 is a table showing parameters used in the method for analyzing membrane-blocking substances of the embodiment, determined from the spectral data shown in FIGS. 4 and 5. 実施例の処理手順の一例を示すフローチャートである。1 is a flowchart illustrating an example of a processing procedure according to an embodiment. 図4及び5で示したスペクトルデータから求めた、比較例の膜閉塞物質の分析方法で用いるパラメータを示す表である。6 is a table showing parameters used in a comparative example of an analytical method for membrane-blocking substances, determined from the spectral data shown in FIGS. 4 and 5 .

次に本発明について図面を用いて説明する。Next, the present invention will be explained with reference to the drawings.

本発明において、「膜閉塞」が生じているとは、膜面の少なくとも一部に膜閉塞物質が付着している状態を意味し、膜閉塞の進行度を限定するものではない。膜閉塞がどの程度進行したら分離膜の洗浄を開始するかは、水処理の目的、被処理水の種類、被処理水の含有成分、透過水の純度等に応じて設定すればよい。本発明が適用可能な分離膜としては、例えば、逆浸透膜、精密ろ過膜、限外ろ過膜、ナノろ過膜、正浸透膜、脱気膜、脱炭酸膜等がある。In the present invention, the occurrence of "membrane blockage" refers to a state in which a membrane-blocking substance is attached to at least a portion of the membrane surface, and does not limit the degree of membrane blockage. The degree to which membrane blockage must progress before cleaning of the separation membrane can be determined according to the purpose of water treatment, the type of water to be treated, the components contained in the water to be treated, the purity of the permeate, etc. Examples of separation membranes to which the present invention can be applied include reverse osmosis membranes, microfiltration membranes, ultrafiltration membranes, nanofiltration membranes, forward osmosis membranes, degassing membranes, and decarbonation membranes.

図1は、本発明の分離膜の薬注制御装置の一構成例を示すブロック図であり、図2は、図1に示した分析装置の一構成例を示す側断面図である。図3は、本発明の分離膜の薬注制御装置の変形例を示すブロック図である。図1~図3で示す本発明の分離膜の薬注制御装置は、分離膜を用いて被処理水を処理する水処理システムの一部を構成するものである。 Figure 1 is a block diagram showing one configuration example of a separation membrane chemical injection control device of the present invention, and Figure 2 is a side cross-sectional view showing one configuration example of the analysis device shown in Figure 1. Figure 3 is a block diagram showing a modified example of the separation membrane chemical injection control device of the present invention. The separation membrane chemical injection control device of the present invention shown in Figures 1 to 3 constitutes part of a water treatment system that treats the water to be treated using a separation membrane.

図1で示すように、本発明の分離膜の薬注制御装置は、被処理水を貯留する原水タンク1と、原水タンク1から供給される被処理水を濃縮水と透過水とに分離する分離膜を備えた膜分離装置2と、膜分離装置2で分離された濃縮水の一部が試験水として供給される、分離膜に付着した膜閉塞物質の種類を特定するための分析装置3と、分離膜を洗浄するための洗浄薬液等を貯留する薬液タンク4と、分離膜の薬注制御装置全体の動作を制御する制御装置5とを有する。図1では、分離膜の薬注制御装置が1つの薬液タンク4を備える構成例を示しているが、分離膜の薬注制御装置は、複数の薬液タンク4を有する構成であってもよい。その場合、複数の薬液タンク4には、それぞれ異なる種類の薬液を貯留してもよい。As shown in FIG. 1, the chemical injection control device for separation membranes of the present invention includes a raw water tank 1 for storing water to be treated, a membrane separation device 2 equipped with a separation membrane for separating the water to be treated supplied from the raw water tank 1 into concentrated water and permeate water, an analyzer 3 for identifying the type of membrane blocking substance attached to the separation membrane, a part of the concentrated water separated by the membrane separation device 2 being supplied as test water, a chemical tank 4 for storing cleaning chemicals for cleaning the separation membrane, and a control device 5 for controlling the operation of the entire chemical injection control device for separation membranes. In FIG. 1, a configuration example in which the chemical injection control device for separation membranes has one chemical tank 4 is shown, but the chemical injection control device for separation membranes may have a configuration having multiple chemical tanks 4. In that case, different types of chemicals may be stored in the multiple chemical tanks 4.

図1で示す分離膜の薬注制御装置は、上記の構成に加えて、原水タンク1から膜分離装置2に被処理水を供給するための原水ポンプ11と、薬液タンク4から水処理システムに薬液を注入するための薬注ポンプ12と、膜分離装置2で分離された濃縮水を外部へ排水するための通水ラインに配置される複数のバルブ13とを備えている。分離膜の薬注制御装置が複数の薬液タンク4を有する場合、該分離膜の薬注制御装置は、薬液タンク4の数に応じて複数の薬注ポンプ12を備えていてもよい。図1では、複数のバルブ13として、膜分離装置2と分析装置3との間の通水ラインに配置される第1のバルブ13Aと、分析装置3と原水タンク1との間の通水ラインに配置される第2のバルブ13Bと、分析装置3へ送水されない膜分離装置2で分離された濃縮水を外部へ排水するための第3のバルブ13Cとを備える構成例を示している。第2のバルブ13Bは、薬液の注入(薬注)時に、膜分離装置2で分離された濃縮水の通水ラインを介して該薬液を原水タンク1へ戻すために設けられている。第2のバルブ13Bは、通常運転時に、濃縮水を原水タンク1へ戻すために用いられることもある。本発明の分離膜の薬注制御装置は、濃縮水または薬液を原水タンク1に戻す構成である必要はない。複数のバルブ13は、分離膜の薬注制御装置の構成や動作に応じて適宜備えていればよい。同様に、複数のポンプは、原水ポンプ11及び薬注ポンプ12に限定されるものではなく、分離膜の薬注制御装置の構成や動作に応じて適宜備えていればよい。In addition to the above configuration, the chemical injection control device for the separation membrane shown in FIG. 1 includes a raw water pump 11 for supplying treated water from the raw water tank 1 to the membrane separation device 2, a chemical injection pump 12 for injecting chemical liquid from the chemical liquid tank 4 into the water treatment system, and a plurality of valves 13 arranged in a water supply line for discharging concentrated water separated by the membrane separation device 2 to the outside. When the chemical injection control device for the separation membrane has a plurality of chemical liquid tanks 4, the chemical injection control device for the separation membrane may include a plurality of chemical injection pumps 12 according to the number of chemical liquid tanks 4. FIG. 1 shows an example of a configuration including a first valve 13A arranged in a water supply line between the membrane separation device 2 and the analysis device 3, a second valve 13B arranged in a water supply line between the analysis device 3 and the raw water tank 1, and a third valve 13C for discharging concentrated water separated by the membrane separation device 2 that is not sent to the analysis device 3 to the outside. The second valve 13B is provided to return the chemical solution to the raw water tank 1 through the concentrated water flow line of the concentrated water separated by the membrane separation device 2 during injection (chemical injection). The second valve 13B may also be used to return the concentrated water to the raw water tank 1 during normal operation. The chemical injection control device for the separation membrane of the present invention does not need to be configured to return the concentrated water or the chemical solution to the raw water tank 1. The multiple valves 13 may be provided as appropriate depending on the configuration and operation of the chemical injection control device for the separation membrane. Similarly, the multiple pumps are not limited to the raw water pump 11 and the chemical injection pump 12, and may be provided as appropriate depending on the configuration and operation of the chemical injection control device for the separation membrane.

原水タンク1に貯留された被処理水は、原水ポンプ11によって膜分離装置2へ供給される。膜分離装置2は、被処理水を、分離膜を透過する物質を含む透過水と、該分離膜を透過しない物質を含む濃縮水とに分離する。透過水は、処理水として排出される。または、透過水は、さらに別の膜分離装置あるいはイオン交換装置等で処理されて処理水として排出される。濃縮水は、排水として放流される。または、濃縮水は、さらに別の膜分離装置、あるいは生物処理装置、固液分離装置等で処理されて排出される。The water to be treated stored in the raw water tank 1 is supplied to the membrane separation device 2 by the raw water pump 11. The membrane separation device 2 separates the water to be treated into permeate containing substances that permeate the separation membrane and concentrated water containing substances that do not permeate the separation membrane. The permeate is discharged as treated water. Alternatively, the permeate is further treated in another membrane separation device or ion exchange device, etc. and discharged as treated water. The concentrated water is discharged as wastewater. Alternatively, the concentrated water is further treated in another membrane separation device, or biological treatment device, solid-liquid separation device, etc. and discharged.

図1で示すように、薬液タンク4に貯留された薬液は、膜分離装置2が備える分離膜の通水ラインに薬注される。薬液は、例えば、原水タンク1に注入されてもよく、原水ポンプ11と膜分離装置2との間の被処理水の通水ラインに注入されてもよく、膜分離装置2と分析装置3との間の濃縮水の通水ラインに注入されてもよい。薬液タンク4に貯留される薬液は、被処理水の種類、被処理水の含有成分等に基づいて、発生が予想される膜閉塞物質の種類や性状等に応じて選定される。薬液の種類としては、膜閉塞物質を溶解除去して分離膜を洗浄するために用いられる酸性薬液、アルカリ性薬液、界面活性剤等がある。薬液には、膜閉塞物質による膜閉塞を抑制する(膜閉塞を遅らせる)ために用いるスライムコントロール剤、スケール分散剤等を用いてもよい。As shown in FIG. 1, the chemical solution stored in the chemical solution tank 4 is injected into the water flow line of the separation membrane equipped in the membrane separation device 2. The chemical solution may be, for example, injected into the raw water tank 1, into the water flow line of the water to be treated between the raw water pump 11 and the membrane separation device 2, or into the water flow line of the concentrated water between the membrane separation device 2 and the analysis device 3. The chemical solution stored in the chemical solution tank 4 is selected based on the type of water to be treated, the components contained in the water to be treated, and the like, according to the type and properties of the membrane blocking substances expected to occur. Types of chemical solutions include acidic chemical solutions, alkaline chemical solutions, surfactants, etc., which are used to dissolve and remove membrane blocking substances and wash the separation membrane. The chemical solution may be a slime control agent, a scale dispersant, etc., which are used to suppress membrane blocking due to membrane blocking substances (to delay membrane blocking).

制御装置5は、原水ポンプ11、薬注ポンプ12及び複数のバルブ13をそれぞれ制御することで本発明の分離膜の薬注制御装置全体の動作を制御する。また、制御装置5は、分析装置3の分析結果に基づいて、薬液タンク4に貯留された薬液を分離膜の通水ラインに注入する。分離膜の薬注制御装置が複数の薬液タンク4を有する場合、制御装置5は、分析装置3で特定された膜閉塞物質の種類に応じて、複数の薬液タンク4で貯留された複数種類の薬液から選択した薬液を分離膜の通水ラインに注入してもよい。分離膜の通水ラインに対する薬注時、制御装置5は、上記第1のバルブ13A及び第2のバルブ13Bを開き、第3のバルブ13Cを閉じることで、薬液を循環させてもよい。制御装置5は、例えば、周知のPLC(Programmable Logic Controller)で実現できる。制御装置5は、CPU(Central Processing Unit)、記憶装置、I/Oインタフェース、通信装置等を備えた周知の情報処理装置(コンピュータ)で実現してもよい。The control device 5 controls the operation of the entire chemical injection control device for the separation membrane of the present invention by controlling the raw water pump 11, the chemical injection pump 12, and the multiple valves 13. The control device 5 also injects the chemical liquid stored in the chemical liquid tank 4 into the water flow line of the separation membrane based on the analysis results of the analysis device 3. When the chemical injection control device for the separation membrane has multiple chemical liquid tanks 4, the control device 5 may inject a chemical liquid selected from multiple types of chemical liquids stored in the multiple chemical liquid tanks 4 into the water flow line of the separation membrane according to the type of membrane blocking substance identified by the analysis device 3. When injecting chemicals into the water flow line of the separation membrane, the control device 5 may circulate the chemical liquid by opening the first valve 13A and the second valve 13B and closing the third valve 13C. The control device 5 can be realized, for example, by a well-known PLC (Programmable Logic Controller). The control device 5 may be realized by a well-known information processing device (computer) equipped with a CPU (Central Processing Unit), a storage device, an I/O interface, a communication device, etc.

図1及び図2で示すように、分析装置3は、原水室31、透過水室32、監視用分離膜33、可視光分光光度計34及び演算装置35を備え、監視用分離膜33が原水室31と透過水室32とを隔てるように設けられた構成である。原水室31、透過水室32及び監視用分離膜33は、監視用セル30を構成する。1 and 2, the analysis device 3 includes a raw water chamber 31, a permeated water chamber 32, a monitoring separation membrane 33, a visible light spectrophotometer 34, and a computing device 35, with the monitoring separation membrane 33 separating the raw water chamber 31 and the permeated water chamber 32. The raw water chamber 31, the permeated water chamber 32, and the monitoring separation membrane 33 constitute a monitoring cell 30.

監視用分離膜33は、膜分離装置2で分離された濃縮水の一部が試験水として供給され、該試験水をさらに濃縮水と透過水とに分離する。監視用分離膜33には、膜分離装置2が備える分離膜と同じ種類の分離膜を用いることが好ましい。さらに、監視用分離膜33には、膜分離装置2が備える分離膜と製造メーカが同じ膜を用いることがより好ましい。A portion of the concentrated water separated by the membrane separation device 2 is supplied as test water to the monitoring separation membrane 33, which further separates the test water into concentrated water and permeate water. It is preferable to use the same type of separation membrane as the separation membrane provided in the membrane separation device 2 for the monitoring separation membrane 33. Furthermore, it is more preferable to use a membrane made by the same manufacturer as the separation membrane provided in the membrane separation device 2 for the monitoring separation membrane 33.

原水室31は、上記試験水が供給され、監視用分離膜33を透過しない物質を含む濃縮水を排出する。監視用分離膜33を透過した物質を含む透過水は透過水室32から排出される。原水室31及び透過水室32は、可視光を透過させる部材でそれぞれ構成され、監視用分離膜33の膜面と対向する原水室31の外壁面に可視光分光光度計34が配置される。原水室31及び透過水室32は、可視光を透過させる部材であれば、どのような部材で構成してもよく、例えば、アクリル板、ガラス板、石英、プラスチック等を用いて構成すればよい。原水室31及び透過水室32は、個別に形成されていてもよく、一体的に形成されていてもよい。The raw water chamber 31 is supplied with the test water and discharges concentrated water containing substances that do not permeate the monitoring separation membrane 33. Permeated water containing substances that have permeated the monitoring separation membrane 33 is discharged from the permeated water chamber 32. The raw water chamber 31 and the permeated water chamber 32 are each made of a material that transmits visible light, and a visible light spectrophotometer 34 is disposed on the outer wall surface of the raw water chamber 31 that faces the membrane surface of the monitoring separation membrane 33. The raw water chamber 31 and the permeated water chamber 32 may be made of any material that transmits visible light, such as an acrylic plate, a glass plate, quartz, or plastic. The raw water chamber 31 and the permeated water chamber 32 may be formed individually or integrally.

可視光分光光度計34は、可視光を照射する照明部と可視光の波長毎の反射強度を測定する測定部とを備え、照明部から監視用分離膜33の膜面に可視光を照射し、該膜面で反射した可視光の波長毎の反射強度を測定部でそれぞれ測定する。可視光分光光度計34の測定部は、400~800nmの可視光領域のうち、少なくとも4つ以上の波長光の反射強度を測定できればよい。例えば、測定部は、波長光400~450nm、450~500nm、600~700nm、700~800nmの領域から、それぞれ少なくとも1つ以上の波長光の反射強度を測定すればよい。照明部は、可視光領域の波長光を照射できればよく、周知のどのような構成でもよい。可視光分光光度計34は、予め設定された所定の周期毎に監視用分離膜33の膜面で反射した可視光の反射強度を測定し、その測定データを演算装置35へ送信する。The visible light spectrophotometer 34 includes an illumination unit that irradiates visible light and a measurement unit that measures the reflection intensity of each wavelength of visible light. The illumination unit irradiates the membrane surface of the monitoring separation membrane 33 with visible light, and the measurement unit measures the reflection intensity of each wavelength of visible light reflected from the membrane surface. The measurement unit of the visible light spectrophotometer 34 may measure the reflection intensity of at least four or more wavelengths of light in the visible light range of 400 to 800 nm. For example, the measurement unit may measure the reflection intensity of at least one or more wavelengths of light from the wavelength light ranges of 400 to 450 nm, 450 to 500 nm, 600 to 700 nm, and 700 to 800 nm. The illumination unit may have any known configuration as long as it can irradiate wavelength light in the visible light range. The visible light spectrophotometer 34 measures the reflection intensity of visible light reflected from the membrane surface of the monitoring separation membrane 33 at a predetermined period set in advance, and transmits the measurement data to the calculation device 35.

演算装置35は、可視光分光光度計34から反射強度の測定データを受信すると、該測定データに基づいて監視用分離膜33の膜面に付着した物質の種類を推定し、推定した物質を分離膜の膜閉塞物質として制御装置5へ通知する。このとき、演算装置35は、監視用分離膜33の膜閉塞の進行度を推定し、その推定結果も併せて制御装置5へ送信してもよい。演算装置35または制御装置5は、膜閉塞物質の推定結果や膜閉塞の進行度の推定結果等を、ディスプレイ装置等の出力装置を用いて、本発明の分離膜の薬注制御装置を含む水処理システムの管理者等に通知してもよい。When the calculation device 35 receives the measurement data of the reflection intensity from the visible light spectrophotometer 34, it estimates the type of substance attached to the membrane surface of the monitoring separation membrane 33 based on the measurement data, and notifies the control device 5 of the estimated substance as a membrane blocking substance of the separation membrane. At this time, the calculation device 35 may estimate the progress of membrane blocking of the monitoring separation membrane 33 and transmit the estimation result to the control device 5 as well. The calculation device 35 or the control device 5 may notify the manager of the water treatment system including the separation membrane chemical injection control device of the present invention of the estimated result of the membrane blocking substance or the estimated result of the progress of membrane blocking, etc., using an output device such as a display device.

なお、図1及び2で示す分離膜の薬注制御装置は、膜分離装置2で分離された濃縮水の一部を試験水として監視用セル30に供給する構成例を示している。本発明の分離膜の薬注制御装置は、図3で示すように、原水タンク1に貯留された被処理水の一部を試験水として監視用セル30に供給する構成としてもよい。その場合、第1のバルブ13Aは、例えば、図3で示すように原水ポンプ11と分析装置3との間の通水ラインに移動させてもよい。1 and 2 show an example of a configuration in which a portion of the concentrated water separated by the membrane separation device 2 is supplied to the monitoring cell 30 as test water. The separation membrane chemical injection control device of the present invention may also be configured to supply a portion of the water to be treated stored in the raw water tank 1 to the monitoring cell 30 as test water, as shown in Figure 3. In that case, the first valve 13A may be moved, for example, to the water flow line between the raw water pump 11 and the analysis device 3, as shown in Figure 3.

本発明では、水処理システムの目的、被処理水の種類、被処理水の含有成分等に基づいて、分離膜で発生が予想される(想定される)1つあるいは複数の膜閉塞物質(以下、想定物質と称す)を選出し、該想定物質毎の可視光における反射強度のデータ(スペクトルデータ)を予め測定する。また、未使用の監視用分離膜(=分離膜、以下、未使用膜と称す)の可視光における反射強度のデータも予め測定する。そして、それらのスペクトルデータから算出された、未使用膜及び想定物質毎の波長光の差に対する反射強度の差である傾き(第1の傾き)及び特定の波長光における反射強度の値を演算装置35の記憶装置でそれぞれ保存しておく。In the present invention, one or more membrane blocking substances (hereinafter referred to as assumed substances) that are expected (assumed) to occur in the separation membrane are selected based on the purpose of the water treatment system, the type of water to be treated, the components contained in the water to be treated, etc., and data on the reflection intensity in visible light (spectral data) for each assumed substance is measured in advance. In addition, data on the reflection intensity in visible light of an unused monitoring separation membrane (= separation membrane, hereinafter referred to as unused membrane) is also measured in advance. Then, the slope (first slope) which is the difference in reflection intensity with respect to the difference in wavelength light for the unused membrane and each assumed substance, calculated from the spectral data, and the value of the reflection intensity at a specific wavelength light are each stored in the memory device of the calculation device 35.

演算装置35は、予め測定された未使用膜及び想定物質の波長光毎の反射強度のデータと、水処理システムが運転されることで、試験水が通水された監視用分離膜(以下、被監視膜と称す)の波長光毎の反射強度のデータとを比較することで膜閉塞物質を特定する。より具体的には、演算装置35は、未使用膜及び想定物質に関して、可視光領域における4つ以上の波長光毎の反射強度のデータをそれぞれ測定し、それらの測定データから求めた、未使用膜及び想定物質毎の反射強度や上記傾きを保存しておく。また、未使用膜及び想定物質毎の反射強度や傾きに基づいて設定された、膜閉塞物質を判別するための判別条件をそれぞれ保存しておく。そして、可視光分光光度計34で被監視膜の波長光毎の反射強度が測定されると、該判別条件を用いて被監視膜の測定データから膜閉塞物質を特定する。The computing device 35 identifies membrane blocking substances by comparing the previously measured data of reflection intensity for each wavelength of light of the unused membrane and the assumed substance with the data of reflection intensity for each wavelength of light of the monitoring separation membrane (hereinafter referred to as the monitored membrane) through which the test water is passed by operating the water treatment system. More specifically, the computing device 35 measures the reflection intensity data for four or more wavelengths of light in the visible light range for the unused membrane and the assumed substance, and stores the reflection intensity and the above-mentioned slope for each unused membrane and assumed substance obtained from the measurement data. In addition, the computing device 35 stores the discrimination conditions for discriminating membrane blocking substances, which are set based on the reflection intensity and slope for each unused membrane and assumed substance. Then, when the reflection intensity for each wavelength of light of the monitored membrane is measured by the visible light spectrophotometer 34, the discrimination conditions are used to identify membrane blocking substances from the measurement data of the monitored membrane.

なお、膜閉塞の進行度を推定する場合、演算装置35は、例えば、上記特許文献1に記載された、監視用分離膜33における濃縮水の透過量の絶対値またはその変化率、監視用分離膜33の透過前後における濃縮水の差圧の絶対値またはその変化率等に基づいて、分離膜の膜閉塞の進行度を推定する方法を用いればよい。In addition, when estimating the degree of membrane blockage, the calculation device 35 may use a method for estimating the degree of membrane blockage of the separation membrane based on, for example, the absolute value or rate of change of the amount of concentrated water permeated through the monitoring separation membrane 33, the absolute value or rate of change of the pressure difference of the concentrated water before and after permeation through the monitoring separation membrane 33, etc., as described in the above Patent Document 1.

反射強度の測定には、可視光領域のうち、400~450nmまたは700~800nmの波長光を必ず含めるようにすることが望ましい。発明者らは、分離膜(監視用分離膜33)の膜面に膜閉塞物質が付着している場合、これらの波長光域における反射強度が、未使用膜のそれよりも低下することを実験等で確認している。したがって、400~450nmまたは700~800nmの波長光を反射強度の測定に含めることで、被監視膜で膜閉塞が生じているか否かを判別できる。It is desirable to always include light with wavelengths of 400 to 450 nm or 700 to 800 nm in the visible light range when measuring reflection intensity. The inventors have confirmed through experiments that when membrane blocking substances are attached to the membrane surface of the separation membrane (monitoring separation membrane 33), the reflection intensity in these wavelength light ranges is lower than that of an unused membrane. Therefore, by including light with wavelengths of 400 to 450 nm or 700 to 800 nm in the reflection intensity measurement, it is possible to determine whether membrane blocking has occurred in the monitored membrane.

演算装置35は、例えば、CPU、記憶装置、I/Oインタフェース、通信装置等を備えた情報処理装置(コンピュータ)で実現すればよい。制御装置5が情報処理装置(コンピュータ)で実現されている場合、演算装置35の機能は制御装置5で実現してもよい。その場合、可視光分光光度計34は、波長光毎の反射強度の測定データを制御装置5へ送信すればよい。可視光分光光度計34と演算装置35(または制御装置5)との通信手段、並びに演算装置35と制御装置5との通信手段は、周知の有線通信手段または無線通信手段のどちらを用いてもよく、その通信規格も周知のどのような規格を用いてもよい。The arithmetic unit 35 may be realized, for example, by an information processing device (computer) equipped with a CPU, a storage device, an I/O interface, a communication device, etc. When the control device 5 is realized by an information processing device (computer), the functions of the arithmetic unit 35 may be realized by the control device 5. In that case, the visible light spectrophotometer 34 may transmit measurement data of the reflection intensity for each wavelength of light to the control device 5. The communication means between the visible light spectrophotometer 34 and the arithmetic unit 35 (or the control device 5), and the communication means between the arithmetic unit 35 and the control device 5 may be either well-known wired communication means or wireless communication means, and the communication standard may be any well-known standard.

上述したように、制御装置5は、分析装置3で特定された膜閉塞物質に基づいて、薬液タンク4に貯留された薬液を分離膜の通水ラインに注入する。例えば、膜閉塞物質がカルシウムスケールであると特定された場合は酸性薬液を注入し、膜閉塞物質がシリカやバイオファウリングであると特定された場合はアルカリ性薬液を注入する。このように膜閉塞物質の種類に応じて適切な洗浄薬液を用いて分離膜を洗浄すれば、該分離膜の機能を回復させることができる。制御装置5は、薬液を注入する前に、純水等を用いて本発明の分離膜の薬注制御装置が備える各通水ラインをそれぞれフラッシングしてもよい。As described above, the control device 5 injects the chemical solution stored in the chemical solution tank 4 into the water flow line of the separation membrane based on the membrane blocking substance identified by the analysis device 3. For example, if the membrane blocking substance is identified as calcium scale, an acidic chemical solution is injected, and if the membrane blocking substance is identified as silica or biofouling, an alkaline chemical solution is injected. In this way, by cleaning the separation membrane with an appropriate cleaning chemical solution depending on the type of membrane blocking substance, the function of the separation membrane can be restored. Before injecting the chemical solution, the control device 5 may flush each water flow line provided in the separation membrane chemical injection control device of the present invention with pure water or the like.

また、制御装置5は、分離膜の膜閉塞の発生を抑制する(遅らせる)ことを目的とする薬液を分離膜の通水ラインに注入してもよい。例えば、膜閉塞物質がバイオファウリングによるスライムであると特定された場合はスライムコントロール剤を薬注し、膜閉塞物質がフッ化カルシウム(CaF)やシリカ等の無機物であると特定された場合はスケール分散剤を薬注すればよい。膜閉塞物質が炭酸カルシウム(CaCO)のようにpHを制御することで膜閉塞の発生を抑制できる物質であれば、酸性薬液やアルカリ性薬液を注入することで膜閉塞の発生を抑制してもよい。 The control device 5 may also inject a chemical solution intended to suppress (delay) the occurrence of membrane clogging into the water line of the separation membrane. For example, if the membrane clogging substance is identified as slime caused by biofouling, a slime control agent may be injected, and if the membrane clogging substance is identified as an inorganic substance such as calcium fluoride (CaF 2 ) or silica, a scale dispersant may be injected. If the membrane clogging substance is a substance that can suppress the occurrence of membrane clogging by controlling the pH, such as calcium carbonate (CaCO 3 ), the occurrence of membrane clogging may be suppressed by injecting an acidic or alkaline chemical solution.

このように水処理システムの稼働時に適切な薬液を注入して分離膜の閉塞を抑制すれば、水処理システムを比較的長い期間にわたって安定して運転することができる。また、膜閉塞物質の発生が抑制されていることが確認された場合は、スライムコントロール剤やスケール分散剤等の注入量を低減することで、水処理システムのランニングコストを低減することも可能である。 In this way, by injecting appropriate chemicals during operation of the water treatment system to prevent clogging of the separation membrane, the water treatment system can be operated stably for a relatively long period of time. Furthermore, if it is confirmed that the generation of membrane-clogging substances is being suppressed, it is also possible to reduce the running costs of the water treatment system by reducing the injection amounts of slime control agents, scale dispersants, etc.

本発明によれば、未使用膜及び想定物質に関して、可視光領域における4つ以上の波長光毎の反射強度のデータをそれぞれ測定し、それらの測定データから求めた未使用膜及び想定物質毎の反射強度や上記傾きを保存しておく。また、未使用膜及び想定物質毎の反射強度や傾きに基づいて予め設定された、膜閉塞物質を判別するための判別条件をそれぞれ保存しておく。そして、可視光分光光度計34で被監視膜の波長光毎の反射強度のデータが測定されると、該判別条件を用いて被監視膜の測定データから膜閉塞物質を特定する。そのため、より多くの膜閉塞物質の種類の特定が可能になる。According to the present invention, data on the reflection intensity of an unused film and an assumed substance for four or more wavelengths of light in the visible light region is measured, and the reflection intensity and the above-mentioned slope for each unused film and assumed substance obtained from the measurement data are stored. In addition, discrimination conditions for discriminating between film blocking substances, which are preset based on the reflection intensity and slope for each unused film and assumed substance, are stored. Then, when the reflection intensity data for each wavelength of light of the monitored film is measured by the visible light spectrophotometer 34, the discrimination conditions are used to identify the film blocking substance from the measurement data of the monitored film. This makes it possible to identify a greater number of types of film blocking substances.

次に本発明の実施例について図面を用いて説明する。Next, an embodiment of the present invention will be described with reference to the drawings.

図4及び5は、想定物質のスペクトルの変化の一例を示すグラフである。 Figures 4 and 5 are graphs showing an example of the change in the spectrum of a hypothetical substance.

本実施例では、上記想定物質を意図的に付着させた複数の分離膜(=監視用分離膜33、以下、閉塞膜と称す)と上記未使用膜とを用意し、可視光分光光度計34を用いて未使用膜及び閉塞膜の波長光毎の反射強度をそれぞれ測定した。可視光分光光度計34には、測定波長範囲が400~1000nmのハイパースペクトルカメラ(RESONON社製、Pika L)を用いた。In this example, multiple separation membranes (= monitoring separation membranes 33, hereafter referred to as blocked membranes) to which the assumed substance was intentionally attached and the unused membrane were prepared, and the reflection intensity of each wavelength of light of the unused membrane and the blocked membrane was measured using a visible light spectrophotometer 34. A hyperspectral camera (Pika L, manufactured by RESONON) with a measurement wavelength range of 400 to 1000 nm was used as the visible light spectrophotometer 34.

閉塞膜には、炭酸カルシウム(CaCO3)、フッ化カルシウム(CaF)、シリカ(SiO)を付着させた分離膜、並びにバイオファウリングさせた分離膜をそれぞれ用意した。そして、稼働ステージ上に未使用膜及び複数の閉塞膜をそれぞれ配置し、未使用膜及び閉塞膜に可視光を照射し、それぞれの膜面で反射した波長光毎の反射強度を上記ハイパースペクトルカメラで測定した。 The blocking membranes were prepared by attaching calcium carbonate (CaCO3), calcium fluoride ( CaF2 ), and silica ( SiO2 ) to the separation membrane, as well as by biofouling. An unused membrane and a number of blocking membranes were placed on the operating stage, and visible light was irradiated onto the unused membrane and the blocking membrane, and the reflection intensity of each wavelength of light reflected from the membrane surface was measured using the hyperspectral camera.

なお、炭酸カルシウム、フッ化カルシウム、シリカを付着させた閉塞膜については、未使用膜と共に波長光450~600nmの範囲で反射強度を測定した。図4のグラフはこれらの分離膜の波長光毎の反射強度(スペクトル)を示している。また、バイオファウリングさせた閉塞膜については、未使用膜と共に波長光400~1000nmの範囲で反射強度を測定した。図5のグラフはこれらの分離膜の波長光毎の反射強度(スペクトル)を示している。ここでは、炭酸カルシウム、フッ化カルシウム、シリカを付着させた閉塞膜と、バイオファウリングさせた閉塞膜とで波長光の測定範囲を変えているが、波長光の測定範囲は、未使用膜と想定物質毎のスペクトルが識別できるように設定すればよく、未使用膜及び想定物質の性状に応じて400~800nmの可視光領域内で適宜設定すればよい。For the blocked membranes with calcium carbonate, calcium fluoride, and silica attached, the reflection intensity was measured in the range of 450 to 600 nm wavelength light, along with the unused membrane. The graph in Figure 4 shows the reflection intensity (spectrum) for each wavelength light of these separation membranes. For the blocked membranes that were biofouled, the reflection intensity was measured in the range of 400 to 1000 nm wavelength light, along with the unused membrane. The graph in Figure 5 shows the reflection intensity (spectrum) for each wavelength light of these separation membranes. Here, the measurement range of wavelength light is different for the blocked membranes with calcium carbonate, calcium fluoride, and silica attached and the blocked membranes that were biofouled, but the measurement range of wavelength light should be set so that the spectrum of the unused membrane and each assumed substance can be distinguished, and should be set appropriately within the visible light region of 400 to 800 nm depending on the properties of the unused membrane and the assumed substance.

次に、上記未使用膜及び閉塞膜の反射強度の測定データ(スペクトルデータ)に基づいて、膜閉塞物質を特定するための分析方法について説明する。Next, we will explain an analytical method for identifying membrane blocking substances based on the measurement data (spectral data) of the reflection intensity of the unused membrane and blocked membrane.

図6は、図4及び5で示した想定物質のスペクトルデータの一例を示す表であり、図7は、図4及び5で示したスペクトルデータから求めた、実施例の膜閉塞物質の分析方法で用いるパラメータを示す表である。 Figure 6 is a table showing an example of spectral data for the assumed substance shown in Figures 4 and 5, and Figure 7 is a table showing parameters used in the analytical method for membrane-blocking substances of the embodiment, determined from the spectral data shown in Figures 4 and 5.

図6は、図4及び5で示した未使用膜及び閉塞膜の反射強度の測定データ(スペクトルデータ)のうち、400nm、450nm、600nm、700nm、800nmの5点の波長光の測定データを抜き出して示している。 Figure 6 shows the measurement data (spectral data) of the reflection intensity of the unused film and blocked film shown in Figures 4 and 5, extracted from the measurement data of light with five wavelengths of 400 nm, 450 nm, 600 nm, 700 nm, and 800 nm.

図7は、図4及び5で示した未使用膜及び閉塞膜の反射強度の測定データから算出した、未使用膜及び想定物質に関する、波長光400及び450nmにおける反射強度の合計値、波長光400及び450nmにおける傾き、波長光600及び800nmにおける傾きをそれぞれ示している。 Figure 7 shows the sum of the reflection intensities at wavelengths of 400 and 450 nm, the slopes at wavelengths of 400 and 450 nm, and the slopes at wavelengths of 600 and 800 nm for an unused film and an assumed substance, calculated from the measurement data of the reflection intensities of the unused film and blocked film shown in Figures 4 and 5, respectively.

上述したように、被監視膜で膜閉塞が生じているか否かは、波長光400~450nmまたは700~800nmにおける未使用膜の反射強度と被監視膜の反射強度とを比較すればよい。但し、1つの波長光の反射強度だけでは差が小さく、判別し難い可能性もある。そこで、本実施例では、図7で示す2つの波長光400及び450nmの反射強度の合計値を用いて、被監視膜で膜閉塞が生じているか否かを判定する。As described above, whether or not film blockage has occurred in the monitored film can be determined by comparing the reflection intensity of the unused film at wavelengths of 400-450 nm or 700-800 nm with the reflection intensity of the monitored film. However, the difference may be small and difficult to determine using only one wavelength of light. Therefore, in this embodiment, the sum of the reflection intensities of the two wavelengths of light, 400 and 450 nm, shown in Figure 7, is used to determine whether or not film blockage has occurred in the monitored film.

未使用膜及び想定物質における傾き(第1の傾き)は、波長光の差に対する該波長光の反射強度の差、すなわち2つの波長光の反射強度の差を該波長光の差で除算することで求めればよい。例えば、波長光600及び800nmにおける傾きは、以下の式で求めればよい。The slope (first slope) for the unused film and the assumed material can be calculated by dividing the difference in the reflection intensity of the wavelength light relative to the difference in the wavelength light, i.e., the difference in the reflection intensity of the two wavelength lights by the difference in the wavelength light. For example, the slope for wavelengths of 600 and 800 nm can be calculated using the following formula:

傾き(600nm、800nm)
=(反射強度800nm-反射強度600nm)/(800nm-600nm)
次に、本実施例の膜閉塞物質の分析方法について、フローチャートを用いて説明する。
Tilt (600 nm, 800 nm)
=(Reflection intensity 800nm-Reflection intensity 600nm)/(800nm-600nm)
Next, the method for analyzing membrane-blocking substances in this embodiment will be described with reference to a flow chart.

図8は、実施例の処理手順の一例を示すフローチャートである。なお、演算装置35は、未使用膜及び想定物質毎の反射強度の測定データから算出された、反射強度の合計値及び傾きの値をそれぞれ保存しているものとする(図7参照)。また、演算装置35は、膜閉塞物質を特定するための判別条件をそれぞれ保存しているものとする。判別条件としては、後述するように、例えば波長光600及び800nmにおける被監視膜の傾きが未使用膜の傾きの2倍以上であるか、波長光400及び450nmにおける被監視膜の傾きが未使用膜の傾きの1.5倍以上であるか、波長光400及び450nmにおける被監視膜の傾きが未使用膜の傾きの0.5倍以下であるか等がある。判別条件は、これらに限定されるものではなく、被監視膜に付着した物質(膜閉塞物質)が判別できるように、未使用膜及び想定物質毎の各波長光における傾き(第1の傾き)に基づいて予め設定しておけばよい。 Figure 8 is a flowchart showing an example of the processing procedure of the embodiment. The calculation device 35 stores the sum of the reflection intensity and the slope value calculated from the measurement data of the reflection intensity for each unused film and assumed substance (see Figure 7). The calculation device 35 also stores the discrimination conditions for identifying the film blocking substance. As described later, the discrimination conditions include, for example, whether the slope of the monitored film at wavelengths of 600 and 800 nm is more than twice the slope of the unused film, whether the slope of the monitored film at wavelengths of 400 and 450 nm is more than 1.5 times the slope of the unused film, whether the slope of the monitored film at wavelengths of 400 and 450 nm is less than 0.5 times the slope of the unused film, etc. The discrimination conditions are not limited to these, and may be set in advance based on the slope (first slope) at each wavelength of the unused film and each assumed substance so that the substance (film blocking substance) attached to the monitored film can be identified.

図8で示すように、演算装置35は、可視光分光光度計34から被監視膜の反射強度の測定データを受信すると、波長光400及び450nmにおける被監視膜の反射強度の合計値を算出し(ステップS1)、被監視膜で膜閉塞が生じているか否かを判定する(ステップS2)。上述したように、演算装置35は、波長光400及び450nmにおける被監視膜の反射強度の合計値が、未使用膜の反射強度の合計値よりも小さい場合に、被監視膜で膜閉塞が生じていると判定すればよい。8, when the calculation device 35 receives measurement data of the reflection intensity of the monitored film from the visible light spectrophotometer 34, it calculates the sum of the reflection intensities of the monitored film at wavelengths of 400 and 450 nm (step S1) and determines whether or not film blockage has occurred in the monitored film (step S2). As described above, the calculation device 35 may determine that film blockage has occurred in the monitored film when the sum of the reflection intensities of the monitored film at wavelengths of 400 and 450 nm is smaller than the sum of the reflection intensities of an unused film.

被監視膜で膜閉塞が生じていないと判定した場合、演算装置35は、ステップS1に戻ってステップS1からの処理を繰り返す。一方、被監視膜で膜閉塞が生じていると判定した場合、演算装置35は、ステップS3の処理に移行して、波長光600及び800nmにおける被監視膜の傾きを算出する。If it is determined that no film blockage has occurred in the monitored film, the calculation device 35 returns to step S1 and repeats the process from step S1. On the other hand, if it is determined that a film blockage has occurred in the monitored film, the calculation device 35 proceeds to step S3 and calculates the slope of the monitored film at wavelengths of 600 and 800 nm.

続いて、演算装置35は、波長光600及び800nmにおける被監視膜の傾きが未使用膜の傾きよりも大きいか(例えば、2倍以上であるか)否かを判定する(ステップS4)。Next, the calculation device 35 determines whether the inclination of the monitored film at wavelengths of 600 and 800 nm is larger (e.g., more than twice as large) than the inclination of the unused film (step S4).

波長光600及び800nmにおける被監視膜の傾きが未使用膜の傾きの2倍以上である場合、図7で示すように膜閉塞物質はバイオファウリングである可能性が高い。この場合、演算装置35は、制御装置5に膜閉塞物質がバイオファウリングである旨を通知するための情報を送信し(ステップS5)、ステップS1の処理に戻ってステップS1からの処理を繰り返す。If the slope of the monitored membrane at wavelengths of 600 and 800 nm is more than twice the slope of the unused membrane, the membrane blocking substance is likely to be biofouling, as shown in Figure 7. In this case, the calculation device 35 transmits information to notify the control device 5 that the membrane blocking substance is biofouling (step S5), and the process returns to step S1 and repeats the process from step S1.

制御装置5は、演算装置35から膜閉塞物質がバイオファウリングである旨が通知されると、分離膜を洗浄する場合は、アルカリ性薬液を注入して分離膜(監視用分離膜33)を洗浄する。また、膜閉塞の発生を抑制する場合は、スライムコントロール剤の薬注量を増加させる。When the control device 5 is notified by the computing device 35 that the membrane blocking substance is biofouling, if the separation membrane is to be cleaned, an alkaline chemical solution is injected to clean the separation membrane (monitoring separation membrane 33). If the occurrence of membrane blockage is to be suppressed, the amount of slime control agent injected is increased.

一方、ステップS4において、波長光600及び800nmにおける被監視膜の傾きが未使用膜の傾きの2倍よりも小さい場合、図7で示すように膜閉塞物質は炭酸カルシウム、シリカまたはフッ化カルシウムである可能性が高い。この場合、演算装置35は、ステップS6の処理に移行して、波長光400及び450nmにおける被監視膜の傾きを算出する。On the other hand, in step S4, if the slope of the monitored film at wavelengths of 600 and 800 nm is less than twice the slope of the unused film, the film blocking substance is likely to be calcium carbonate, silica, or calcium fluoride, as shown in Figure 7. In this case, the calculation device 35 proceeds to the process of step S6 and calculates the slope of the monitored film at wavelengths of 400 and 450 nm.

続いて、演算装置35は、波長光400及び450nmにおける被監視膜の傾きが未使用膜の傾きよりも大きいか(例えば、1.5倍以上であるか)否かを判定する(ステップS7)。Next, the calculation device 35 determines whether the inclination of the monitored film at wavelengths of 400 and 450 nm is larger than the inclination of the unused film (e.g., 1.5 times or more) (step S7).

波長光400及び450nmにおける被監視膜の傾きが未使用膜の傾きの1.5倍以上である場合、図7で示すように膜閉塞物質は炭酸カルシウムである可能性が高い。この場合、演算装置35は、制御装置5に膜閉塞物質が炭酸カルシウムである旨を通知するための情報を送信し(ステップS8)、ステップS1の処理に戻ってステップS1からの処理を繰り返す。If the slope of the monitored film at wavelengths of 400 and 450 nm is 1.5 times or more the slope of the unused film, the film blocking substance is likely to be calcium carbonate, as shown in Figure 7. In this case, the calculation device 35 transmits information to notify the control device 5 that the film blocking substance is calcium carbonate (step S8), and the process returns to step S1 and repeats the process from step S1.

制御装置5は、演算装置35から膜閉塞物質が炭酸カルシウムである旨が通知されると、分離膜を洗浄する場合は、酸性薬液を注入して分離膜(監視用分離膜)を洗浄する。また、膜閉塞の発生を抑制する場合は、酸性薬液またはアルカリ性薬液を注入してpHを制御することで膜閉塞の発生を抑制する。When the control device 5 is notified by the computing device 35 that the membrane blocking substance is calcium carbonate, in case of cleaning the separation membrane, it injects an acidic chemical solution to clean the separation membrane (monitoring separation membrane). In addition, in case of suppressing the occurrence of membrane blockage, it suppresses the occurrence of membrane blockage by injecting an acidic or alkaline chemical solution to control the pH.

ステップS7において、波長光400及び450nmにおける被監視膜の傾きが未使用膜の傾きの1.5倍よりも小さい場合、図7で示すように膜閉塞物質はシリカまたはフッ化カルシウムである可能性が高い。この場合、演算装置35は、ステップS9の処理に移行して、波長光400及び450nmにおける被監視膜の傾きが未使用膜の傾きよりも小さいか(例えば、0.5倍以下)否かを判定する。In step S7, if the slope of the monitored film at wavelengths of 400 and 450 nm is less than 1.5 times the slope of the unused film, the film blocking substance is likely to be silica or calcium fluoride, as shown in Figure 7. In this case, the computing device 35 proceeds to the process of step S9 and determines whether the slope of the monitored film at wavelengths of 400 and 450 nm is smaller (e.g., 0.5 times or less) than the slope of the unused film.

波長光400及び450nmにおける被監視膜の傾きが未使用膜の傾きの0.5倍以下である場合、図7で示すように膜閉塞物質はシリカである可能性が高い。この場合、演算装置35は、制御装置5に膜閉塞物質がシリカである旨を通知するための情報を送信し(ステップS10)、ステップS1の処理に戻ってステップS1からの処理を繰り返す。If the slope of the monitored film at wavelengths of 400 and 450 nm is less than 0.5 times the slope of the unused film, the film blocking substance is likely to be silica, as shown in Figure 7. In this case, the calculation device 35 transmits information to notify the control device 5 that the film blocking substance is silica (step S10), and the process returns to step S1 and repeats the process from step S1.

制御装置5は、演算装置35から膜閉塞物質がシリカである旨が通知されると、分離膜を洗浄する場合は、アルカリ性薬液を注入して分離膜(監視用分離膜33)を洗浄する。また、膜閉塞の発生を抑制する場合は、スケール分散剤の薬注量を増加させる。制御装置5は、酸性薬液またはアルカリ性薬液を注入してpHを制御することで膜閉塞の発生を抑制してもよい。 When the control device 5 is notified by the computing device 35 that the membrane blocking substance is silica, if the separation membrane is to be cleaned, an alkaline chemical solution is injected to clean the separation membrane (monitoring separation membrane 33). If membrane blockage is to be suppressed, the amount of scale dispersant injected is increased. The control device 5 may also suppress the occurrence of membrane blockage by injecting an acidic or alkaline chemical solution to control the pH.

一方、波長光400及び450nmにおける被監視膜の傾きが未使用膜の傾きの0.5倍よりも大きい場合、図7で示すように膜閉塞物質はフッ化カルシウムである可能性が高い。この場合、演算装置35は、制御装置5に膜閉塞物質がフッ化カルシウムである旨を通知する情報を送信し(ステップS11)、ステップS1の処理に戻ってステップS1からの処理を繰り返す。On the other hand, if the slope of the monitored film at wavelengths of 400 and 450 nm is greater than 0.5 times the slope of the unused film, the film blocking substance is likely to be calcium fluoride, as shown in Figure 7. In this case, the calculation device 35 transmits information to the control device 5 notifying that the film blocking substance is calcium fluoride (step S11), and the process returns to step S1 and repeats the process from step S1.

制御装置5は、演算装置35から膜閉塞物質がフッ化カルシウムである旨が通知されると、分離膜を洗浄する場合は、酸性薬液を注入して分離膜(監視用分離膜)を洗浄する。また、膜閉塞の発生を抑制する場合は、スケール分散剤の薬注量を増加させる。制御装置5は、酸性薬液またはアルカリ性薬液を注入してpHを制御することで膜閉塞の発生を抑制してもよい。 When the control device 5 is notified by the computing device 35 that the membrane blocking substance is calcium fluoride, if the separation membrane is to be cleaned, an acidic chemical solution is injected to clean the separation membrane (monitoring separation membrane). If membrane blockage is to be suppressed, the amount of scale dispersant injected is increased. The control device 5 may suppress membrane blockage by injecting an acidic or alkaline chemical solution to control the pH.

本実施例では、上記想定物質が、炭酸カルシウム、フッ化カルシウム、シリカ及びバイオファウリングである場合の膜閉塞物質を特定するための一例を示した。想定物質が上記以外にも考えられる場合、それらの物質毎に予め4つ以上の波長光毎の反射強度を測定し、図7で示したように物質毎の反射強度の合計値や特定の波長光における傾きを求めて膜閉塞物質の特定に用いればよい。例えば、想定物質として、バリウム塩、カルシウム塩、マグネシウム塩、金属錯体等が考えられる場合、予めそれらの物質の可視光における4つ以上の波長光の反射強度を測定し、図7で示したように物質毎の反射強度の合計値や特定の波長光における傾きを求めて、膜閉塞物質の特定に用いればよい。In this embodiment, an example for identifying membrane blocking substances when the assumed substances are calcium carbonate, calcium fluoride, silica, and biofouling is shown. If the assumed substances are other than those mentioned above, the reflection intensity of four or more wavelengths of light for each substance can be measured in advance, and the total value of the reflection intensity for each substance and the slope at a specific wavelength of light can be obtained as shown in FIG. 7, and used to identify membrane blocking substances. For example, if barium salts, calcium salts, magnesium salts, metal complexes, etc. are considered as assumed substances, the reflection intensity of four or more wavelengths of light in visible light for each substance can be measured in advance, and the total value of the reflection intensity for each substance and the slope at a specific wavelength of light can be obtained as shown in FIG. 7, and used to identify membrane blocking substances.

比較例Comparative Example

本比較例では、上記実施例で示した膜閉塞物質の特定方法と上記特許文献2が示す膜閉塞物質の特定方法とを比較した結果について説明する。In this comparative example, we explain the results of comparing the method for identifying membrane-blocking substances shown in the above examples with the method for identifying membrane-blocking substances shown in Patent Document 2 above.

図9は、図4及び5で示したスペクトルデータから求めた、比較例の膜閉塞物質の分析方法で用いるパラメータを示す表である。 Figure 9 is a table showing the parameters used in the comparative example analysis method for membrane-blocking substances, determined from the spectral data shown in Figures 4 and 5.

図9は、特許文献2で用いるカラーセンサで測定可能な光の三原色である赤(R:波長光466nm)、緑(G:波長光532nm)、青(B:波長光630nm)における、上記実施例で示した想定物質毎の測定データから求めた傾きをそれぞれ示している。 Figure 9 shows the slopes obtained from the measurement data for each of the assumed substances shown in the above examples for red (R: wavelength of light 466 nm), green (G: wavelength of light 532 nm), and blue (B: wavelength of light 630 nm), which are the three primary colors of light that can be measured by the color sensor used in Patent Document 2.

図9で示すように、波長光466nm、532nm、630nmにおける未使用膜及び想定物質毎の傾きを比較すると、未使用膜とフッ化カルシウムとでは、それぞれの傾きがほぼ等しいことが分かる。また、炭酸カルシウム、シリカ及びバイオファウリングについても、それぞれの傾きがほぼ等しいことが分かる。As shown in Figure 9, when comparing the slopes of the unused membrane and each assumed substance at wavelengths of 466 nm, 532 nm, and 630 nm, it can be seen that the slopes of the unused membrane and calcium fluoride are almost the same. It can also be seen that the slopes of calcium carbonate, silica, and biofouling are almost the same.

したがって、炭酸カルシウム、フッ化カルシウム、シリカ及びバイオファウリングが想定物質として考えられる場合、特許文献2で示す膜閉塞物質の特定方法では、未使用膜とフッ化カルシウムとを識別することが困難であり、炭酸カルシウム、シリカ及びバイオファウリングを識別することが困難である。すなわち、炭酸カルシウム、フッ化カルシウム、シリカ及びバイオファウリングが想定物質として考えられる場合、特許文献2が示す膜閉塞物質の特定方法では膜閉塞物質を特定できないことが分かる。 Therefore, when calcium carbonate, calcium fluoride, silica, and biofouling are considered to be the assumed substances, it is difficult to distinguish between an unused membrane and calcium fluoride, and it is difficult to distinguish between calcium carbonate, silica, and biofouling, using the method for identifying membrane blocking substances shown in Patent Document 2. In other words, when calcium carbonate, calcium fluoride, silica, and biofouling are considered to be the assumed substances, it is clear that the method for identifying membrane blocking substances shown in Patent Document 2 cannot identify membrane blocking substances.

それに対して、本発明では、上記実施例で示したように、これらの物質を判別することが可能であり、特定した膜閉塞物質に基づいて適切な薬液を選択することで、分離膜を洗浄できる、または膜閉塞の発生を抑制できる。In contrast, in the present invention, as shown in the above examples, it is possible to distinguish between these substances, and by selecting an appropriate chemical solution based on the identified membrane-blocking substance, it is possible to clean the separation membrane or suppress the occurrence of membrane blockage.

以上、実施形態及び実施例を参照して本願発明を説明したが、本願発明は上記実施形態に限定されものではない。本願発明の構成や詳細には本願発明のスコープ内で当業者が理解し得る様々な変更が可能である。The present invention has been described above with reference to the embodiments and examples, but the present invention is not limited to the above embodiments. Various modifications that can be understood by a person skilled in the art are possible in the configuration and details of the present invention within the scope of the present invention.

Claims (8)

試験水が通水された監視用分離膜に可視光を照射し、
前記監視用分離膜で反射した前記可視光の反射強度を可視光分光光度計で測定し、
測定した前記可視光の前記反射強度に基づいて膜の閉塞物質を特定し、
前記膜の閉塞物質を特定する工程は、
未使用の前記監視用分離膜である未使用膜及び想定される前記膜の閉塞物質である想定物質の前記反射強度を測定し、
前記未使用膜及び前記想定物質における前記可視光の波長光の差に対する前記反射強度の差である第1の傾きをそれぞれ算出し、
前記未使用膜及び前記想定物質の前記第1の傾きと、400~450nmまたは700~800nmの波長光における前記未使用膜の前記反射強度とを保存し、
前記試験水が通水された前記監視用分離膜である被監視膜の前記可視光の前記反射強度を測定し、
前記400~450nmまたは700~800nmの波長光における、前記被監視膜の前記反射強度が前記未使用膜の前記反射強度よりも小さいとき、前記被監視膜が閉塞していると判定し、
前記被監視膜における、前記可視光の波長光の差に対する前記反射強度の差である第2の傾きを算出し、
前記第1の傾きと前記第2の傾きとを比較することで、前記被監視膜を閉塞させている前記膜の閉塞物質を特定する、膜閉塞物質の分析方法。
Visible light is irradiated onto the monitoring separation membrane through which the test water has been passed,
measuring the reflection intensity of the visible light reflected by the monitoring separation membrane with a visible light spectrophotometer;
identifying an obstructing substance in the membrane based on the measured reflected intensity of the visible light;
The step of identifying a membrane obstructing substance comprises:
Measure the reflection intensity of an unused membrane, which is the unused monitoring separation membrane, and an assumed substance, which is an assumed clogging substance of the membrane;
Calculating a first slope, which is a difference in reflection intensity with respect to a difference in wavelength of visible light in the unused film and the assumed substance, respectively;
storing the first gradient of the unused film and the assumed substance, and the reflection intensity of the unused film at a wavelength of 400 to 450 nm or 700 to 800 nm;
measuring the reflection intensity of the visible light from the monitored membrane, which is the monitoring separation membrane through which the test water is passed;
determining that the monitored film is clogged when the reflection intensity of the monitored film is smaller than the reflection intensity of the unused film for the light of the wavelength of 400 to 450 nm or 700 to 800 nm;
calculating a second gradient, which is a difference in reflection intensity with respect to a difference in wavelength of the visible light in the monitored film;
The method for analyzing a membrane clogging substance includes comparing the first gradient with the second gradient to identify a membrane clogging substance that is clogging the monitored membrane.
400nm~800nmの可視光領域のうち、4つ以上の波長光の前記反射強度に基づいて前記膜の閉塞物質を特定する、請求項1に記載の膜閉塞物質の分析方法。 The method for analyzing membrane blocking substances according to claim 1, which identifies the membrane blocking substances based on the reflection intensity of four or more wavelengths of light in the visible light region of 400 nm to 800 nm. 前記可視光領域のうち、400nm~450nm、450nm~500nm、600nm~700nm及び700nm~800nmの各領域でそれぞれ測定した、少なくとも1つ以上の波長光の前記反射強度に基づいて前記膜の閉塞物質を特定する、請求項2に記載の膜閉塞物質の分析方法。 The method for analyzing membrane blocking substances according to claim 2, wherein the membrane blocking substances are identified based on the reflection intensity of at least one or more wavelengths of light measured in each of the visible light ranges of 400 nm to 450 nm, 450 nm to 500 nm, 600 nm to 700 nm, and 700 nm to 800 nm. 試験水が通水される監視用分離膜と、
前記監視用分離膜に可視光を照射し、前記監視用分離膜で反射した前記可視光の反射強度を測定する可視光分光光度計と、
測定した前記可視光の前記反射強度に基づいて膜の閉塞物質を特定する演算装置と、
を有し、
前記演算装置は、
前記可視光分光光度計で測定された未使用の前記監視用分離膜である未使用膜及び想定される前記膜の閉塞物質である想定物質の前記反射強度から、前記未使用膜及び前記想定物質における、前記可視光の波長光の差に対する前記反射強度の差である第1の傾きをそれぞれ算出し、前記未使用膜及び前記想定物質の前記第1の傾きと、400~450nmまたは700~800nmの波長光における前記未使用膜の前記反射強度とを保存し、
前記可視光分光光度計で測定された前記試験水が通水された前記監視用分離膜である被監視膜の前記可視光の前記反射強度に基づき、前記400~450nmまたは700~800nmの波長光における、前記被監視膜の前記反射強度が前記未使用膜の前記反射強度よりも小さいときに前記被監視膜が閉塞していると判定し、前記被監視膜における前記可視光の波長光の差に対する前記反射強度の差である第2の傾きを算出し、前記第1の傾きと前記第2の傾きとを比較することで、前記被監視膜を閉塞させている前記膜の閉塞物質を特定する膜閉塞物質の分析装置。
A monitoring separation membrane through which test water is passed;
a visible light spectrophotometer that irradiates the monitoring separation membrane with visible light and measures the reflection intensity of the visible light reflected by the monitoring separation membrane;
a computing device for identifying an obstructing substance in the membrane based on the measured reflection intensity of the visible light;
having
The computing device includes:
A first slope, which is a difference in reflection intensity with respect to a difference in wavelength light of the visible light in the unused membrane and the assumed substance, is calculated from the reflection intensity of the unused membrane, which is the unused monitoring separation membrane, measured by the visible light spectrophotometer, and the assumed substance, which is an assumed clogging substance of the membrane, and the first slope of the unused membrane and the assumed substance, and the reflection intensity of the unused membrane in the wavelength light of 400 to 450 nm or 700 to 800 nm are stored;
This membrane blocking substance analysis device determines that the monitored membrane is blocked when the reflection intensity of the monitored membrane, which is the monitoring separation membrane through which the test water has been passed, is smaller than the reflection intensity of the unused membrane at the 400 to 450 nm or 700 to 800 nm wavelength light based on the reflection intensity of the visible light reflected by the monitored membrane measured by the visible light spectrophotometer, calculates a second slope which is the difference in reflection intensity relative to the difference in wavelength light of the visible light in the monitored membrane, and compares the first slope with the second slope to identify the blocking substance in the membrane that is blocking the monitored membrane.
前記演算装置は、
400nm~800nmの可視光領域のうち、4つ以上の波長光の前記反射強度に基づいて前記膜の閉塞物質を特定する、請求項4に記載の膜閉塞物質の分析装置。
The computing device includes:
5. The apparatus for analyzing membrane clogging substances according to claim 4, wherein the membrane clogging substances are identified based on the reflection intensities of four or more wavelengths of light in the visible light region of 400 nm to 800 nm.
前記演算装置は、
前記可視光領域のうち、400nm~450nm、450nm~500nm、600nm~700nm及び700nm~800nmの各領域でそれぞれ測定した、少なくとも1つ以上の波長光の前記反射強度に基づいて前記膜の閉塞物質を特定する、請求項5に記載の膜閉塞物質の分析装置。
The computing device includes:
The apparatus for analyzing membrane blocking substances according to claim 5, wherein the membrane blocking substances are identified based on the reflection intensity of at least one or more wavelengths of light measured in each of the visible light ranges of 400 nm to 450 nm, 450 nm to 500 nm, 600 nm to 700 nm, and 700 nm to 800 nm.
被処理水を分離膜により透過水と濃縮水とに分離し、
前記濃縮水の一部を試験水として監視用分離膜に通水し、
前記試験水が通水された前記監視用分離膜に可視光を照射し、
前記監視用分離膜で反射した前記可視光の反射強度を可視光分光光度計で測定し、
測定した前記可視光の前記反射強度に基づいて前記分離膜を閉塞させる膜閉塞物質を特定し、
前記膜閉塞物質を特定する工程は、
未使用の前記監視用分離膜である未使用膜及び想定される前記膜閉塞物質である想定物質の前記反射強度を測定し、
前記未使用膜及び前記想定物質における前記可視光の波長光の差に対する前記反射強度の差である第1の傾きをそれぞれ算出し、
前記未使用膜及び前記想定物質の前記第1の傾きと、400~450nmまたは700~800nmの波長光における前記未使用膜の前記反射強度とを保存し、
前記試験水が通水された前記監視用分離膜である被監視膜の前記可視光の前記反射強度を測定し、
前記400~450nmまたは700~800nmの波長光における、前記被監視膜の前記反射強度が前記未使用膜の前記反射強度よりも小さいとき、前記被監視膜が閉塞していると判定し、
前記被監視膜における、前記可視光の波長光の差に対する前記反射強度の差である第2の傾きを算出し、
前記第1の傾きと前記第2の傾きとを比較することで、前記被監視膜を閉塞させている前記膜閉塞物質を特定し、
特定された前記膜閉塞物質を溶解除去する薬液、または特定された前記膜閉塞物質による膜閉塞を抑制する薬液を、前記分離膜の通水ラインに薬注する、分離膜の薬注制御方法。
The water to be treated is separated into permeate and concentrated water by a separation membrane;
A part of the concentrated water is passed through a monitoring separation membrane as test water,
Irradiating the monitoring separation membrane through which the test water has passed with visible light;
measuring the reflection intensity of the visible light reflected by the monitoring separation membrane with a visible light spectrophotometer;
identifying a membrane blocking substance that blocks the separation membrane based on the measured reflection intensity of the visible light;
The step of identifying the membrane-occluding substance comprises:
Measure the reflection intensity of an unused membrane, which is the unused monitoring separation membrane, and an assumed substance, which is the assumed membrane blocking substance;
Calculating a first slope, which is a difference in reflection intensity with respect to a difference in wavelength of visible light in the unused film and the assumed substance, respectively;
storing the first gradient of the unused film and the assumed substance, and the reflection intensity of the unused film at a wavelength of 400 to 450 nm or 700 to 800 nm;
measuring the reflection intensity of the visible light from the monitored membrane, which is the monitoring separation membrane through which the test water is passed;
determining that the monitored film is clogged when the reflection intensity of the monitored film is smaller than the reflection intensity of the unused film for the light of the wavelength of 400 to 450 nm or 700 to 800 nm;
calculating a second gradient, which is a difference in reflection intensity with respect to a difference in wavelength of the visible light in the monitored film;
identifying the membrane blocking substance blocking the monitored membrane by comparing the first gradient with the second gradient;
A chemical injection control method for a separation membrane, comprising injecting a chemical solution for dissolving and removing the identified membrane-clogging substance, or a chemical solution for suppressing membrane clogging due to the identified membrane-clogging substance, into a water flow line of the separation membrane.
被処理水を透過水と濃縮水とに分離する分離膜を備えた膜分離装置と、
前記濃縮水の一部が試験水として通水される監視用分離膜と、
前記試験水が通水された前記監視用分離膜に可視光を照射し、前記監視用分離膜で反射した前記可視光の反射強度を測定する可視光分光光度計と、
測定した前記可視光の前記反射強度に基づいて前記分離膜を閉塞させる膜閉塞物質を特定する演算装置と、
特定された前記膜閉塞物質を溶解除去する薬液、または特定された前記膜閉塞物質による膜閉塞を抑制する薬液を、前記分離膜の通水ラインに薬注する制御装置と、
を有し、
前記演算装置は、
前記可視光分光光度計で測定された未使用の前記監視用分離膜である未使用膜及び想定される前記膜閉塞物質である想定物質の前記反射強度から、前記未使用膜及び前記想定物質における、前記可視光の波長光の差に対する前記反射強度の差である第1の傾きをそれぞれ算出し、前記未使用膜及び前記想定物質の前記第1の傾きと、400~450nmまたは700~800nmの波長光における前記未使用膜の前記反射強度とを保存し、
前記可視光分光光度計で測定された前記試験水が通水された前記監視用分離膜である被監視膜の前記可視光の前記反射強度に基づき、前記400~450nmまたは700~800nmの波長光における、前記被監視膜の前記反射強度が前記未使用膜の前記反射強度よりも小さいときに前記被監視膜が閉塞していると判定し、前記被監視膜における前記可視光の波長光の差に対する前記反射強度の差である第2の傾きを算出し、前記第1の傾きと前記第2の傾きとを比較することで、前記被監視膜を閉塞させている前記膜閉塞物質を特定する分離膜の薬注制御装置。
A membrane separation device having a separation membrane that separates the water to be treated into permeate and concentrated water;
A monitoring separation membrane through which a portion of the concentrated water is passed as test water;
a visible light spectrophotometer for irradiating visible light onto the monitoring separation membrane through which the test water has passed and measuring the reflection intensity of the visible light reflected by the monitoring separation membrane;
a calculation device that identifies a membrane clogging substance that causes the separation membrane to be clogged based on the measured reflection intensity of the visible light;
A control device that injects a chemical solution for dissolving and removing the identified membrane blocking substance or a chemical solution for suppressing membrane blocking due to the identified membrane blocking substance into a water flow line of the separation membrane;
having
The computing device includes:
A first slope, which is a difference in reflection intensity with respect to a difference in wavelength light of the visible light in the unused membrane and the assumed substance, is calculated from the reflection intensity of the unused membrane, which is the unused monitoring separation membrane, and the assumed substance, which is the assumed membrane blocking substance, measured by the visible light spectrophotometer, and the first slope of the unused membrane and the assumed substance and the reflection intensity of the unused membrane in the wavelength light of 400 to 450 nm or 700 to 800 nm are stored;
A separation membrane drug injection control device that determines that the monitored membrane is clogged when the reflection intensity of the monitored membrane at wavelengths of 400 to 450 nm or 700 to 800 nm is smaller than the reflection intensity of the unused membrane based on the reflection intensity of the visible light of the monitored membrane, which is the monitoring separation membrane through which the test water has been passed, measured by the visible light spectrophotometer, calculates a second slope, which is the difference in reflection intensity relative to the difference in wavelengths of the visible light in the monitored membrane, and identifies the membrane blocking substance that is blocking the monitored membrane by comparing the first slope with the second slope.
JP2023518644A 2021-05-06 2022-03-30 Method and apparatus for analyzing membrane blocking substances, and method and apparatus for controlling chemical injection into separation membrane Active JP7579439B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021078659 2021-05-06
JP2021078659 2021-05-06
PCT/JP2022/016068 WO2022234751A1 (en) 2021-05-06 2022-03-30 Analysis method and analysis device for membrane-occluding substance, and chemical-solution injection control method and chemical-solution injection control device for separation membrane

Publications (2)

Publication Number Publication Date
JPWO2022234751A1 JPWO2022234751A1 (en) 2022-11-10
JP7579439B2 true JP7579439B2 (en) 2024-11-07

Family

ID=83932160

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023518644A Active JP7579439B2 (en) 2021-05-06 2022-03-30 Method and apparatus for analyzing membrane blocking substances, and method and apparatus for controlling chemical injection into separation membrane

Country Status (3)

Country Link
JP (1) JP7579439B2 (en)
TW (1) TW202308751A (en)
WO (1) WO2022234751A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012106237A (en) 2010-10-21 2012-06-07 Nitto Denko Corp Membrane separation apparatus, membrane separation apparatus operation method and evaluation method using the membrane separation apparatus
JP2016107235A (en) 2014-12-10 2016-06-20 水ing株式会社 Analysis method for contaminated condition of separation membrane, evaluation method for water quality of filtration object water using the same, and filtration system for performing analysis method for contaminated condition of separation membrane
JP2019505779A (en) 2015-12-23 2019-02-28 ケミラ オサケュスティオユルキネン Method and apparatus for deposit formation monitoring and control
JP2019155257A (en) 2018-03-12 2019-09-19 栗田工業株式会社 Method for evaluating contamination state of separation membrane
JP2019166463A (en) 2018-03-23 2019-10-03 栗田工業株式会社 Film surface observation cell, and operation method of separation membrane module
US20200096438A1 (en) 2014-12-10 2020-03-26 King Abdullah University Of Science And Technology In-line quantification and characterization of membrane fouling

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012106237A (en) 2010-10-21 2012-06-07 Nitto Denko Corp Membrane separation apparatus, membrane separation apparatus operation method and evaluation method using the membrane separation apparatus
JP2016107235A (en) 2014-12-10 2016-06-20 水ing株式会社 Analysis method for contaminated condition of separation membrane, evaluation method for water quality of filtration object water using the same, and filtration system for performing analysis method for contaminated condition of separation membrane
US20200096438A1 (en) 2014-12-10 2020-03-26 King Abdullah University Of Science And Technology In-line quantification and characterization of membrane fouling
JP2019505779A (en) 2015-12-23 2019-02-28 ケミラ オサケュスティオユルキネン Method and apparatus for deposit formation monitoring and control
JP2019155257A (en) 2018-03-12 2019-09-19 栗田工業株式会社 Method for evaluating contamination state of separation membrane
JP2019166463A (en) 2018-03-23 2019-10-03 栗田工業株式会社 Film surface observation cell, and operation method of separation membrane module

Also Published As

Publication number Publication date
JPWO2022234751A1 (en) 2022-11-10
TW202308751A (en) 2023-03-01
WO2022234751A1 (en) 2022-11-10

Similar Documents

Publication Publication Date Title
JP6446451B2 (en) Automatic analyzer
KR101334330B1 (en) Treatment System and Method for Ballast Water
US20210146367A1 (en) Water Testing Systems and Devices
KR20090038573A (en) UV Sterilizer Control System and Control Method
JP7579439B2 (en) Method and apparatus for analyzing membrane blocking substances, and method and apparatus for controlling chemical injection into separation membrane
JP2003126855A (en) Membrane filtration system
JP5013000B2 (en) UV absorbance measuring device
JP2007093398A (en) Measuring method of concentration of residual chlorine and measuring instrument therefor
US20160101389A1 (en) Method of performing a cleaning operation on a water filtration device
JP4696593B2 (en) Method of using ultrafiltration filter and wet developing device with ultrafiltration filter regeneration mechanism
KR102218025B1 (en) Method and apparatus for inspection of polymeric membrane aging in water treatment process
US10280093B2 (en) Water treatment method, water treatment apparatus, and non-transitory computer-readable recording medium storing program
JP2019053016A (en) Computer program, fluorescence measurement device and method for estimating fouling progression speed
JP7667722B2 (en) METHOD AND APPARATUS FOR DETERMINING MEMBRANE DETERIORATION, METHOD AND APPARATUS FOR CONTROLLING CHEMICAL INJECTION, AND WATER TREATMENT SYSTEM
KR100613401B1 (en) Developing system for color filters
TW202003098A (en) Membrane clean device and method for cleaning membrane
JP7270490B2 (en) Water supply equipment and water supply method for cooling towers
JPH11179173A (en) Operation method of membrane separator and membrane separator
JP3646541B2 (en) Hypochlorous acid concentration control method in electrolyzed water supply device
KR20230102178A (en) Apparatus and method for processing substrate
JP7215497B2 (en) Water quality analyzer
JPH1119485A (en) Operation control method in water treatment using membrane
JP6897380B2 (en) Water treatment system
US12318518B2 (en) Blood purification device
KR102864560B1 (en) ICT-based Water Quality Management System and Water Quality Management Method of Swimming Pool

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230802

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240319

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240409

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240730

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240924

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241022

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241025

R150 Certificate of patent or registration of utility model

Ref document number: 7579439

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150